Literature DB >> 15181221

Reliability of Hong Kong Chinese version of the Patient-rated Forearm Evaluation Questionnaire for lateral epicondylitis.

H B Leung1, C H Yen, P Y T Tse.   

Abstract

OBJECTIVE: To determine the reliability and validity of a dedicated assessment tool for lateral epicondylitis after translation into Hong Kong Chinese.
DESIGN: Cross-sectional study.
SETTING: District hospital, Hong Kong. PATIENTS: Seventy-four patients, 12 of whom were bilingual, were recruited (total of 82 elbows). MAIN OUTCOME MEASURES: Translation equivalence and reliability were measured with the test-retest method. Validity was measured against the Roles and Maudsley outcome score and mean maximal grip strength. RESULT: The Patient-rated Forearm Evaluation Questionnaire had high English-Chinese equivalence (Spearman's rho correlation coefficient=0.926; P<0.001). It was also very reliable (intraclass correlation coefficient=0.99; P<0.001). Validity according to the Roles and Maudsley outcome score and mean of maximal grip strength was significant (P<0.01).
CONCLUSION: The Hong Kong Chinese version of Patient-rated Forearm Evaluation Questionnaire is a reliable and valid assessment tool for chronic lateral epicondylitis. Its equivalence to the original English version makes outcome assessment across cultural barrier feasible.

Entities:  

Mesh:

Year:  2004        PMID: 15181221

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  8 in total

1.  Evaluation of the reliability and validity of the Persian version of Patient-Rated Elbow Evaluation questionnaire.

Authors:  Mohammad Reza Farazdaghi; Ali Mansoori; Omid Vosoughi; Amin Kordi Yoosefinejad
Journal:  Rheumatol Int       Date:  2016-11-30       Impact factor: 2.631

2.  Reliability and validity of Turkish version of the patient rated tennis elbow evaluation.

Authors:  Lale Altan; Ilker Ercan; Saniye Konur
Journal:  Rheumatol Int       Date:  2009-08-26       Impact factor: 2.631

3.  Relationships between biomechanics, tendon pathology, and function in individuals with lateral epicondylosis.

Authors:  Amrish O Chourasia; Kevin A Buhr; David P Rabago; Richard Kijowski; Kenneth S Lee; Michael P Ryan; Jessica M Grettie-Belling; Mary E Sesto
Journal:  J Orthop Sports Phys Ther       Date:  2013-03-18       Impact factor: 4.751

4.  Cross-cultural adaptation and reliability and validity of the Dutch Patient-Rated Tennis Elbow Evaluation (PRTEE-D).

Authors:  Mathijs van Ark; Johannes Zwerver; Ronald L Diercks; Inge van den Akker-Scheek
Journal:  BMC Musculoskelet Disord       Date:  2014-08-11       Impact factor: 2.362

5.  Randomised, prospective, non-blinded pilot study comparing the effect of intramuscular steroid injections and intralesional steroid injections in the management of tennis elbow.

Authors:  Hasan Tahir; Izolda Biro; Simon Donnelly; Mandy Greenwood
Journal:  BMJ Open Sport Exerc Med       Date:  2017-02-10

6.  Therapeutic effects of acupuncture plus fire needle versus acupuncture alone in lateral epicondylitis: A randomized case-control pilot study.

Authors:  Szu-Ying Wu; Cheng-Nan Lu; Chia-Jung Chung; Chun-En Kuo; Jer-Ming Sheen; Tun-Pin Hsueh; Ching-Chih Chen; Kuo-Wei Bi
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Efficacy of ultrasound therapy for the treatment of lateral elbow tendinopathy (the UCICLET Trial): study protocol for a three-arm, prospective, multicentre, randomised controlled trial.

Authors:  Ziyang Sun; Shuai Chen; Weixuan Liu; Guixin Sun; Junjian Liu; Jian Wang; Wei Wang; Yuanyi Zheng; Cunyi Fan
Journal:  BMJ Open       Date:  2022-01-17       Impact factor: 2.692

8.  Cross-cultural adaptation and determination of the reliability and validity of PRTEE-S (Patientskattad Utvärdering av Tennisarmbåge), a questionnaire for patients with lateral epicondylalgia, in a Swedish population.

Authors:  Pia Nilsson; Amir Baigi; Bertil Marklund; Jörgen Månsson
Journal:  BMC Musculoskelet Disord       Date:  2008-06-05       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.